Alnylam, Bayer, Boehringer Ingelheim, and Novo Nordisk will collaborate with PRECISE to analyze whole-genome and other data on 100,000 Singaporeans.

Borussia Dortmund’s form has been sputtering lately, and now they are dealt the unfortunate hand of a trip to face one of the ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.

At the behest of the pharmaceutical lobby — and after millions in political donations — Republican lawmakers have defanged ...

Bayer's successful trial comes after it previously halted a phase 3 clinical trial testing the effectiveness of the same experimental drug for stroke and systemic embolism prevention in 2023. At the ...

Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German ...

MORGANTOWN, W.Va. (WBOY) — WBOY+ has teamed up to present the WVU Medicine Golisano Children’s Hospital Thanksgiving Parade — “A Morning of Magic and Meaning.” The parade will be shown live on the ...

A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Bayer AG won US approval for its new medicine Hyrnuo to treat a common form of lung cancer as the German company works to bolster its drug pipeline.